OncoHost raises $35 million to further develop and test its precision oncology platform, combining proprietary bioinformatics, signal processing, and machine learning.
,” Dr. Sharon observed that “most patients, unfortunately, are not responding to treatment, and the problem is that when you start treating your patient, you do not know which patient will respond or not. Sometimes up to six or even nine months into therapy. So we are wasting a lot of time, we’re wasting a lot of money. And most importantly, we are losing time for our patients.”
OncoHost’s precision oncology platform predicts the trajectory for the first 12 months of treatment and the company tests have shown that the predicted response and measured response meshed very closely. In addition, by mapping resistance, OncoHost can direct physicians to the right treatment pathways, and identify potential new combinations to mitigate resistance. “Obviously, a 78-year-old lady and a 45-year-old man are not the same patient,” Dr. Sharon says.
The company’s target market of late-stage immunotherapy-treated cancer patients represents expenditure of about $6 billion, Dr. Sharon estimates. The proteomics market is expected to grow to $50 billion in 2027 from $21.1 billion in 2019. “With promising and significant clinical results, OncoHost’s unique approach can create a brighter and better future for the world of precision oncology, maximizing the likelihood of selecting the correct therapy combinations and dramatically improving therapeutic results for cancer patients. We are confident that Oncohost is set to become a pivotal proteomics market leader in personalized oncology treatment,” Prof.
OncoHost continues to open additional clinical trial sites around the world and will be expanding its research to further cancer indications. PROphet, its precision oncology platform, is set to launch in the U.S. in the third quarter of 2022.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Irene Zhao’s influencer platform SO-COL is raising funds at a $100 million valuationA startup founded by crypto influencer Irene Zhao is raising new funds at a $100 million valuation in a round led by Blockchain Capital.
Read more »
Sixers make donation to Jefferson Health after assistant coach Dave Joerger’s cancer treatmentJoerger was diagnosed with head and neck cancer in October and went through seven weeks of radiation and chemotherapy at Jefferson Health. He returned to the Sixers' bench in early February.
Read more »
Slutty Vegan Founder Pinky Cole Raises $25 Million In Series A Funding Round With New Voices Fund And Enlightened Hospitality Investments As Lead InvestorsIn a For(bes) the Culture exclusive, Cole says she has raised $25 million through a Series A funding round that values her four-year-old brand at $100 million. RaquelHarrisTV
Read more »
Slutty Vegan Founder Pinky Cole Raises $25 Million In Series A Funding Round With New Voices Fund And Enlightened Hospitality Investments As Lead InvestorsIn a For(bes) the Culture exclusive, Cole says she has raised $25 million through a Series A funding round that values her four-year-old brand at $100 million.
Read more »
Granger ISD voters approve $44M bond election to address growthThe $44 million bond includes a new secondary high school campus, new baseball and softball fields, a new football stadium and renovations and upgrades to the existing elementary school.
Read more »
Transgender treatment, doctors threatened by new Alabama lawTwo physicians who run a clinic in Alabama to treat children with gender dysphoria are bracing themselves now that a law that makes some of their work a crime has gone into effect.
Read more »